Labcon North America

This project is comprised of two elements:

1. Zoning Map Amendment (ZMA) and associated amendment to the Lakeville Business Park Planned Community Development (Lakeville PCD): The ZMA is requested to change the zoning designation for 6.51-acres from Planned Unit Community District (PCD) to Business Park (BP) and an amendment to the Lakeville PCD to remove all references to the parcels that comprise the 6.51-acres that are subject to the zoning map amendment. This amendment is requested to have the site under a single, standard BP zone. The Lakeville PCD will otherwise remain as adopted by City Council Resolution 2016-173.
2. Site Plan and Architectural Review (SPAR) - New Construction: SPAR is requested to allow for the construction of a new manufacturing building with ±176,000 square feet of floor area, associated parking, and other on-site improvements. Proposed site improvements include five full-size loading berths and one smaller loading berth, 132 new paved parking spaces (to include stalls reserved for electric vehicles, fuel-efficient vehicles, and high occupancy vehicles), and 138 new landscaped parking reserve spaces (to support future parking demand, if required). The new building would overlap with a portion of the existing ±103,000 square foot building to provide for an all-weather and secure connection (each building would otherwise not be connected and thus the proposed building is not considered an addition).

Post construction, the 16.33-acre parcel would include ±288,000 square feet of total floor area, with Labcon North America using ±247,000 square feet as a manufacturing, warehousing, and distribution facility, and Steris Corporation using ±40,000 square feet as a sterilization facility

The Labcon North America Expansion Project would be funded in part by a $59.3 million contract award from the U.S. Department of Defense on behalf of and in coordination with the U.S. Department of Health and Human Services. According to the applicant, the award was granted to support Labcon's production of pipette tips and tubes as part of the supply chain for COVID-19 diagnostic testing.